Valerio Therapeutics Société anonyme Balance Sheet Health
Financial Health criteria checks 3/6
Valerio Therapeutics Société anonyme has a total shareholder equity of €23.2M and total debt of €12.8M, which brings its debt-to-equity ratio to 55.3%. Its total assets and total liabilities are €44.0M and €20.8M respectively.
Key information
55.3%
Debt to equity ratio
€12.81m
Debt
Interest coverage ratio | n/a |
Cash | €16.83m |
Equity | €23.18m |
Total liabilities | €20.84m |
Total assets | €44.02m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ALVIO's short term assets (€21.6M) exceed its short term liabilities (€12.1M).
Long Term Liabilities: ALVIO's short term assets (€21.6M) exceed its long term liabilities (€8.8M).
Debt to Equity History and Analysis
Debt Level: ALVIO has more cash than its total debt.
Reducing Debt: ALVIO's debt to equity ratio has increased from 0.2% to 55.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if ALVIO has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ALVIO has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.